Furthermore, the G177C genetic polymorphism of ALAD alters lead toxicokinetics and adverse effects of lead exposure, and ALADCG/CC genotype is associated with reduced death rate from all causes and from cancer (47). The gene discussed is ALAD; the disease is cancer.